Literature DB >> 10747969

The noncatalytic beta-propeller domain of prolyl oligopeptidase enhances the catalytic capability of the peptidase domain.

Z Szeltner1, V Renner, L Polgár.   

Abstract

Prolyl oligopeptidase, which is involved in memory disorders, is a member of a new family of serine peptidases. In addition to the peptidase domain, the enzyme contains a beta-propeller, which excludes large peptides from the active site. The enzyme is inhibited with thiol reagents, possibly by reacting with Cys-255 located close to the substrate binding site. This assumption was tested with the Cys-255 --> Thr, Cys-255 --> Ala, and Cys-255 --> Ser variants of prolyl oligopeptidase. In contrast to the wild type enzyme, the Cys-255 --> Thr variant was not inhibited with N-ethylmaleimide, indicating that Cys-255, of the 16 free cysteine residues, exclusively accounts for the enzyme inhibition. Unlike the wild type enzyme that showed a doubly bell-shaped pH rate profile, the modified enzyme displayed a single bell-shaped pH dependence with benzyloxycarbonyl-Gly-Pro-naphthylamide. It was the high pH form of the enzyme that virtually disappeared with all three enzyme variants. A substantial reduction was also observed in k(cat)/K(m) for the aminobenzoyl-Ser-Pro-Phe(NO(2))-Ala-OH substrate. The high pK(a) (9.77) of Cys-255 determined by titration with N-ethylmaleimide excluded the possibility that ionization of the thiol group was responsible for generation of the two active enzyme forms. The impaired activity of the enzyme variants could be rationalized in terms of weaker binding, which manifests itself in high K(m) for substrates and high K(i) for inhibitors, like benzyloxycarbonyl-Gly-Pro-OH and aminobenzoyl-Ser-d-Pro-Phe(NO(2))-Ala-OH. It was concluded that, besides selecting substrates by size, the beta-propeller domain containing Cys-255 remarkably contributed to catalysis of the peptidase domain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10747969     DOI: 10.1074/jbc.M000942200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Catalysis of serine oligopeptidases is controlled by a gating filter mechanism.

Authors:  V Fülöp; Z Szeltner; L Polgár
Journal:  EMBO Rep       Date:  2000-09       Impact factor: 8.807

2.  Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for coeliac sprue.

Authors:  Lu Shan; Thomas Marti; Ludvig M Sollid; Gary M Gray; Chaitan Khosla
Journal:  Biochem J       Date:  2004-10-15       Impact factor: 3.857

3.  Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis.

Authors:  Jofre Tenorio-Laranga; Francisco Coret-Ferrer; Buenaventura Casanova-Estruch; María Burgal; J Arturo García-Horsman
Journal:  J Neuroinflammation       Date:  2010-04-06       Impact factor: 8.322

4.  Mycobacterium tuberculosis Prolyl Oligopeptidase Induces In vitro Secretion of Proinflammatory Cytokines by Peritoneal Macrophages.

Authors:  Brina Portugal; Flávia N Motta; Andre F Correa; Diego O Nolasco; Hugo de Almeida; Kelly G Magalhães; Ana L V Atta; Francisco D Vieira; Izabela M D Bastos; Jaime M Santana
Journal:  Front Microbiol       Date:  2017-02-07       Impact factor: 5.640

5.  Dynamics and ligand-induced conformational changes in human prolyl oligopeptidase analyzed by hydrogen/deuterium exchange mass spectrometry.

Authors:  Alexandra Tsirigotaki; Roos Van Elzen; Pieter Van Der Veken; Anne-Marie Lambeir; Anastassios Economou
Journal:  Sci Rep       Date:  2017-05-26       Impact factor: 4.379

6.  Kinetic Landscape of a Peptide Bond-Forming Prolyl Oligopeptidase.

Authors:  Clarissa M Czekster; James H Naismith
Journal:  Biochemistry       Date:  2017-04-07       Impact factor: 3.162

7.  Mechanism of Action of Prolyl Oligopeptidase (PREP) in Degenerative Brain Diseases: Has Peptidase Activity Only a Modulatory Role on the Interactions of PREP with Proteins?

Authors:  Pekka T Männistö; J Arturo García-Horsman
Journal:  Front Aging Neurosci       Date:  2017-02-14       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.